“
“Emulsion-based crystallization to produce spherical crystalline agglomerates (SAs) is an attractive route to control

crystal size during downstream processing of active pharmaceutical ingredients (APIs). However, conventional methods of emulsification in stirred vessels pose several problems that limit the utility of emulsion-based crystallization. In this paper, we use capillary microfluidics Epoxomicin mw to generate monodisperse water-in-oil emulsions. Capillary microfluidics, in conjunction with evaporative crystallization on a flat heated surface, enables controllable production of uniformly sized SAs of glycine in the 35-150 mu m size range. We report detailed characterization of particle size, size distribution, structure, and polymorphic

form. Further, online high-speed stereomicroscopic observations reveal several clearly demarcated stages in the dynamics of glycine crystallization from emulsion droplets. Rapid droplet shrinkage is followed by crystal nucleation within individual droplets. Once a nucleus is formed within a droplet, crystal growth is very rapid (<0.1 s) and occurs linearly along radially advancing fronts at speeds of up to 1 mm/s, similar to spherulitic crystal growth from impure melts. The spherulitic aggregate thus formed ages to yield the final SA morphology. Overall crystallization times are on the order of minutes, as compared to hours in conventional batch processes. We discuss these phenomena and their implications www.selleckchem.com/products/ipi-145-ink1197.html for the development of more generalized processes applicable to a variety of drug molecules. This work paves the way for microfluidics-enabled continuous spherical crystallization processes.”
“Objective: The purpose of the present study was to identify the risk factors associated with passenger decisions to ride with a driver who is under the influence of either alcohol or cannabis. Method: We analyzed data from the 2008 Canadian Alcohol and Drug Use Monitoring Survey MK-2206 (CADUMS), a nationally represented telephone sample of 16,672 Canadians age 15 and older, of whom 60.5% were female. Logistic regression

analyses explored the effects of sociodemographic, substance use, and driving-behavior factors on the risk of riding with a drinking driver (RWDD) and riding with a cannabis-impaired driver (RWCD). Results: Risk factors for RWDD and RWCD were both shared and unique. Common risk factors were respondents’ age, with young people at increased risk and those 65 years and older at decreased risk, and problematic alcohol use (as measured by Alcohol Use Disorder Identification Test subscales). Having previously driven under the influence of alcohol increased the risk of RWDD, while RWCD was associated with having previously driven under the influence of cannabis. Conclusions: Considerable legal and public health attention has been devoted to eliminating impaired driving, with particular focus on driver behavior.